Nutritional aspects in hemodialysis

Kidney International, Supplement

Volumn 58, Issue 76, 2000, Pages

  Laville, M ^a   Fouque, D ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Diet and dialysis; Growth factors; Malnutrition; Uremia

Indexed keywords

AMINO ACID; GLUCOSE; GROWTH HORMONE; INSULIN; PROTEIN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; VITAMIN;

ACIDOSIS; ANOREXIA; ARTICLE; BIOCOMPATIBILITY; CARDIOVASCULAR DISEASE; DIET RESTRICTION; DIETARY INTAKE; FEMALE; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; INFECTION; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PRIORITY JOURNAL; UREMIA; CHRONIC KIDNEY FAILURE; DIET THERAPY; NUTRITIONAL STATUS; PROTEIN CALORIE MALNUTRITION; RENAL REPLACEMENT THERAPY; REVIEW;

HUMANS; KIDNEY FAILURE, CHRONIC; NUTRITIONAL STATUS; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS;

EID: 0033865304     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.07617.x     Document Type: Article

References (82)

1. Nutritional status and lymphocyte function in maintenance hemodialysis patients
2. Statistical selection of nutritional parameters in hemodialysed patients
3. Nutritional status of haemodialysis patients: A French national cooperative study
4. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987
5. Report on management of renal failure in Europe, XXV, 1994: End stage renal disease and dialysis report
6. Survival in long term haemodialysis patients: Results of the annual survey of the Japanese society for dialysis therapy
7. Nutrition and mortality in hemodialysis
8. Serum albumin is a strong predictor of death in chronic dialysis patients
9. Predictors of mortality in hemodialysis patients
10. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease
11. Malnutrition in hemodialysis patients
12. Markers for survival in dialysis: A seven-year prospective study
13. Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis
14. Malnutrition as the main factor of morbidity and mortality in hemodialysis patients
15. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
16. Canadian hemodialysis morbidity study
17. The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis
18. Urea index (Kt/V) and other predictors of hemodialysis patient survival
19. Methods for assessing nutritional status of patients with chronic renal failure
20. Why are dialysis patients malnourished?
21. Effect of dose of dialysis on morbidity and mortality
22. The dose of hemodialysis and patient mortality
23. Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients
24. Effect of the dialysis membrane on mortality of chronic hemodialysis patients
25. Hospitalization in dialysis patients
26. Nutritional and metabolic response to catabolic stress in chronic uremia
27. Zech Increase of serum insulin-like growth factor I (IGF 1) during chronic renal failure is reduced by low-protein diet
28. Dietary compliance to a low protein and phosphate diet in patients with chronic renal failure
29. The quality of life of patients with end-stage renal disease
30. Nutrition and adequacy of dialysis in hemodialysis patients
31. Spontaneous dietary intake during progression of chronic renal failure
32. Protein intake in renal disease
33. IGF-1, a marker of undernutrition in hemodialysis patients
34. The hemodialysis pilot study: Nutrition program and participant characteristics at baseline: The HEMO Study Group
35. National Kidney Foundation DOQI guidelines in nutrition
36. Taste buds and neuronal markers in patients with chronic renal failure
37. Hypogueusia and zinc depletion in chronic dialysis patients
38. Factors underlying abnormal zinc metabolism in uremia
39. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat
40. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial
41. Increased plasma leptin concentration in end-stage renal disease
42. Acute leptin regulation in end-stage renal failure: The role of growth hormone and IGF-1
43. Role of the kidney in human leptin metabolism
44. Molecular studies of leptin: Implications for renal disease
45. A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients
46. Plasma C-reactive protein in haemodialysis
47. Biological basis of hypoalbuminemia in ESRD
48. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood
49. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure
50. Nitrogen balance in intermittent hemodialysis therapy
51. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans
52. The free and bound amino acids removed by hemodialysis
53. Amino acid and albumin losses during hemodialysis
54. Dialyzer reuse: A currently acceptable practice
55. Dialysate protein losses with bleach processed polysulphone dialyzers
56. The metabolic effects of hemodialysis with and without glucose in the dialysate
57. Hemodialysis-associated protein catabolism with and without glucose in the dialysis fluid
58. Vitamin nutrition in patients undergoing maintenance hemodialysis
59. Folic acid status of patients with chronic renal failure maintained by dialysis
60. Vitamin B12 levels and nerve conduction velocities in patients undergoing maintenance hemodialysis
61. The effect of dialysis on plasma and tissue levels of vitamin C
62. Ascorbic acid depletion during hemodialysis
63. Homeostasis of folic acid in patients undergoing maintenance hemodialysis
64. Ascorbic acid depletion in patients undergoing chronic hemodialysis
65. Water soluble vitamins in chronic hemodialysis patients and need for supplementation
66. Vitamin B6 deficiency in uremia and its implications for the depression of immune responses
67. Daily requirement for pyridoxine supplements in chronic renal failure
68. Erythropoietin and oxidative stress in hemodialysis: Beneficial effects of vitamin E supplementation
69. Glucose intolerance in uremia: Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin
70. Insulin-like growth factor-1 (IGF-1) resistance in renal failure
71. Impaired metabolic response to ecombinant human insulin-like growth factor-1 in dialysis patients
72. Mechanisms for defects in muscle protein metabolisms in rats with chronic uremia
73. Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation
74. Low protein diet in uremia: Effects on glucose metabolism and energy production rate
75. Use of intradialytic parenteral nutrition in hemodialysis patients
76. The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients
77. Growth hormone treatment of children with chronic renal insufficiency, end-stage renal disease and following renal transplantation: Update 1997
78. Effects of recombinant human growth hormone on plasma and dialysate amino acid profiles in CAPD patients
79. Recombinant human growth hormone therapy in malnourished dialysis patients: A randomized controlled study
80. Double-blind, placebocontrolled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: Anabolic effect and functional improvement
81. Recombinant human IGF-1 induces an anabolic response in malnourished CAPD patients